EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.165 | n-octylglucoside | 20-30% enhancement of activity with the proteins that behave as good acceptors: fetuin, alpha1-glycoprotein and human chorionic gonadotropin. 3fold enhancement of activity of the poor acceptor glycophorin | Sus scrofa | |
2.4.1.165 | Triton X-100 | 0.5%, 2fold increment in activity | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.165 | Triton X-100 | - |
Homo sapiens | |
2.4.1.165 | Triton X-100 | 0.5%, inhibition | Sus scrofa |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.1.165 | microsome | - |
Sus scrofa | - |
- |
2.4.1.165 | soluble | large amounts of the enzyme is released in soluble form, particularly when CaCo-2 cells are maintained in culture for more than 3 weeks in order to ensure an higher degree of enterocyte differentiation | Sus scrofa | - |
- |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.165 | Mn2+ | - |
Homo sapiens | |
2.4.1.165 | Mn2+ | required | Sus scrofa |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.165 | UDP-N-acetyl-D-galactosamine + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | Homo sapiens | - |
UDP + N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | Sus scrofa | - |
UDP + N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.165 | Homo sapiens | - |
- |
- |
2.4.1.165 | Rattus norvegicus | - |
- |
- |
2.4.1.165 | Sus scrofa | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.4.1.165 | partial | Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.165 | cecum | - |
Homo sapiens | - |
2.4.1.165 | cecum | - |
Rattus norvegicus | - |
2.4.1.165 | cecum | - |
Sus scrofa | - |
2.4.1.165 | large intestine | - |
Homo sapiens | - |
2.4.1.165 | large intestine | - |
Sus scrofa | - |
2.4.1.165 | proximal colon | - |
Homo sapiens | - |
2.4.1.165 | proximal colon | - |
Sus scrofa | - |
EC Number | Storage Stability | Organism |
---|---|---|
2.4.1.165 | -20 C, microsomal fraction, 1 year without significant loss of activity | Sus scrofa |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.165 | additional information | - |
Homo sapiens | ? | - |
? | |
2.4.1.165 | additional information | the enzyme strictly recognizes the NeuAcalpha2,3Galbeta terminal sequence of N- and O-linked oligosaccharides bound to glycoproteins | Sus scrofa | ? | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | - |
Homo sapiens | UDP + N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | - |
Sus scrofa | UDP + N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + alpha1-acid glycoprotein | - |
Homo sapiens | UDP + N-acetylgalactosaminyl-alpha1-acid glycoprotein | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + alpha1-acid glycoprotein | - |
Sus scrofa | UDP + N-acetylgalactosaminyl-alpha1-acid glycoprotein | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + asialofetuin | - |
Homo sapiens | UDP + N-acetylgalactosaminylasialofetuin | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + asialofetuin | - |
Sus scrofa | UDP + N-acetylgalactosaminylasialofetuin | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + fetuin | - |
Homo sapiens | UDP + N-acetylgalactosaminylfetuin | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + fetuin | - |
Sus scrofa | UDP + N-acetylgalactosaminylfetuin | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + human chorionic gonadotropin | - |
Homo sapiens | UDP + N-acetylgalactosaminyl human chorionic gonadotropin | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + human chorionic gonadotropin | - |
Sus scrofa | UDP + N-acetylgalactosaminyl human chorionic gonadotropin | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + NeuAcalpha(2-3)Galbeta(1-4)Glc | - |
Homo sapiens | UDP + GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glc | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + NeuAcalpha(2-3)Galbeta(1-4)Glc | - |
Sus scrofa | UDP + GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glc | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + NeuAcalpha(2-3)Galbeta(1-4)GlcNAc | - |
Sus scrofa | UDP + GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glc | - |
? | |
2.4.1.165 | UDP-N-acetyl-D-galactosamine + NeuAcalpha(2-3)Galbeta(1-4)GlcNAc | i.e. 3'-sialyllactosamine | Homo sapiens | UDP + GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glc | - |
? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.4.1.165 | 7.4 | - |
- |
Sus scrofa |